Neslihan Arife Kaya

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma

Phuong H. D. Nguyen, Siming Ma, Cheryl Zi Jin Phua et al. · Nature Communications · 2021 · 135 citations · Full text

Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial

David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 117 citations

Hepatology, Hepatocellular Carcinoma, Single Arm +10

Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma

Samuel Chuah, Joycelyn Jie Xin Lee, Yuan Song et al. · Journal of Hepatology · 2022 · 113 citations · Full text

Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study

Weiwei Zhai, Hannah Lai, Neslihan Arife Kaya et al. · National Science Review · 2021 · 73 citations · Full text

Engineering, Genetics, Pathology +19

Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis

Dogan Can Kirman, Bhuvanasundar Renganathan, Wai Kit Chui et al. · Cell Death and Disease · 2022 · 18 citations · Full text